Vous êtes sur la page 1sur 48

CARE Ratings – JOURNEY TOWARDS EXCELLENCE

1
Significance of Credit Rating
for Funding Options

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Presentation Structure

• Funding Options

• What is Credit Rating & its process

• Credit Rating Services for Enterprises

• Benefits of Rating Services

• About & Why CARE Ratings

CARE Ratings – JOURNEY TOWARDS EXCELLENCE 3


Funding Options

Equity
 Own Resources (Friends, relatives etc.)
 Venture Capital (VC) /Private Equity
 Initial Public Offer (IPO)/Private Placements
Debt
 Institutional Finance
• Bank term loans and working capital facilities
• Loans from financial institutions
 Capital Market Instruments
• Bonds / Debentures / Structured Products
• Commercial paper (CP)
 Fixed Deposit (FD)

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


What does investor looks for

Safety of Investment

Return on Investment

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


How do you convince investor?

OPTION I - You do the talking….

Is it very effective?? May be yes or no…

OPTION II – Let others talk about you:

Much more effective

Need for Third Party Assessment

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


What is Credit Rating & its process

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Concept of credit ratings

“Credit rating is, essentially, an


independent, unbiased and objective
opinion on the relative ability and
willingness of the issuer of a debt
instrument to meet the debt service
obligations as and when they arise.”

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Rating Scale
Investment Grade Speculative Grade

AAA BB
AA B
Long
Term A C

BBB D

PR1+
PR1 PR4
Short
Term PR2 PR5

PR3

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Key Parameter Evaluated

Industry Risk

Business Risk

Management Evaluation

Financial Risk

Project Risk

CARE Ratings – JOURNEY TOWARDS EXCELLENCE 10


Industry Risk

Regulatory Environment Demand-Supply Gap Cyclicality / Seasonality


• Govt. Policy • Trend Analysis – • Sensitivity to economic cycle
Stable/Growing/Declining
• Govt. Priority Level • Rating “Through the Cycle”
• Market Size
• International Competition / • Product Life Cycle
Restrictions • Investment plans of
existing/new players
• Role of Regulators E.g. ERC,
TRAI etc.

Input Related Risk Industry Financials Industry Competition


• Availability • Aggregate Industry Financials • No. of players, entry barriers,
input related risk, bargaining
• Price Volatility • Aggregate Industry Ratios
power of suppliers / buyers,
substitute products etc.

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Business Risk
Location Product/Business Mix
Availability of Utilities Mkt. & Distribution
Availability of Raw R&D Edge
Materials
Manpower
Cost Structure
Capacity Utilization Environmental Regulations

Level of Integration Size of the Company

Technology

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Management Evaluation
Industry Experience Support from / Propensity
to support Group
Composition of Board
Companies
Risk Management Approach
Integrity / Ethics
Debt Servicing Track Record
Management Succession
Management Proactiveness
Labour Relations
Past Successful strategies
Policies & Processes
Ability to meet projections

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Financial Risk
Financial Risk

Past Financials Projected Financials


Growth in Revenues Growth Assumptions

Profitability Cash Flow Adequacy

Solvency DSCR

Liquidity Financial Flexibility

Quality of Accounts

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Project Risk
Project Risk
Project Rationale – Expansion, Integration, Diversification

Financial Flexibility

Resource Mobilisation

Necessary Approvals & Clearances

Size of the Project

Management’s Experience in Project Implementation

Project Viability

Post Implementation Risk – Financial Risk & Business Risk

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


In nutshell

Credit Risk

Industry Risk Business Risk Mgmt. Evaln. Financial Risk

Industry Market Position Track Record Existing Fin. Position


Characteristics

Industry Financials Operating Efficiency Credibility Cash flow adequacy

Strategic initiatives Financial Flexibility

Others Accounting Quality

External Risk Internal Risk

For Companies with Capex, Project Risk is also considered

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Rating/Grading Services
Banks and FI
IPO Grading & ratings
SME/SSI
Equi-Grade
ratings

Structured
Corporate
Finance
ratings
Ratings

Sub-
Infrastructure
sovereign
ratings
ratings
Services
Corporate
Issuer
Governance
Rating
ratings

Insurance/ Construction
CPA ratings Grading
Fund credit
Grading of
Quality
MTI
rating

CARE Ratings – JOURNEY TOWARDS EXCELLENCE 17


Rating/Grading Services For Enterprises

CARE Ratings – JOURNEY TOWARDS EXCELLENCE 18


Bank Facility Rating under Basel-II
framework
Banks are required to arrive at their capital requirements
for loan/facility exposures to various entities using
stipulated risk weights.

These risk weights are linked to the credit ratings of


loans/facility assigned by RBI/SEBI recognized rating
agencies such as CARE.

An unrated loan/facility exposure by the Bank gets a


higher risk weight whereas a rated exposure gets lower
risk rate.
CARE Ratings – JOURNEY TOWARDS EXCELLENCE 19
Credit Risk & Ratings

Mapping of Rating & Risk Weights (Corporates)


Long Term

CARE AAA AA A BBB


RW (%) 20 30 50 100

Short Term

CARE PR1+ PR1 PR2 PR3

RW (%) 20 30 50 100

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Credit Risk & Ratings

Unrated fresh sanction/renewals attract higher risk weight

> `50cr exposure (aggregate basis) by Apr’08

> `10cr
10cr exposure (aggregate basis) by Apr’09

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Implications

Banks are likely to price their exposures on the basis of rating.

Better rated borrowers can get credit facilities at lower rate of interest on
account of lower capital requirement of banks.

An illustration

For every `100/- lent to a AAA rated borrower, bank will have to keep aside
capital of `1.80 whereas for unrated borrower, it will need capital of `13.50.

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Debt Instruments
 Rating of all types of medium and long term debt
securities

 Long tern instruments such as debentures, bonds


and convertible bonds.

 Short term debt obligation such as Commercial


Paper, Inter-corporate deposits, fixed deposits and
certificates of deposits.

CARE Ratings – JOURNEY TOWARDS EXCELLENCE 23


SME Rating/NSIC – CARE SSI
Rating
 An issue specific, one-time assessment of the credit risk of entity
 Comparison with credit risk of other SMEs.
 Considers credit risk over one year horizon,
 Reflects the overall debt-management capability.
 NSIC- CARE SSI Rating subsidised rating fee
Turnover (` Lakh)
Particulars < 50 50-200 >200
Rating Fees (`) 27,000 35,000 47,000
Service Tax @ 10.3 % (`) 2,781 3,605 4,841
Total Fees (`) 29,781 38,605 51,841
Subsidy from NSIC (`) 22,336 28,954 38,881
Amount payable by SSI (`) 7,445 9,651 12,960

CARE Ratings – JOURNEY TOWARDS EXCELLENCE 24


Credit Rating Process
CLIENT CARE

Request for Rating Assigns rating team

Submits information and


detailed schedules The team analyses the information

Interacts with team, responds to


queries and provides additional Team interacts with client, undertakes site
data necessary for the analysis. visits and analyses data submitted by client

RATING COMMITTEE awards rating.


Rating Letter & rationale issued to client

Accepts Yes
Press Release, published in website,
Rating?
CAREVIEW and Rating Reckoner

No Rating Kept Under Periodic Surveillance

Appeal for Review of


rating
(once)

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Benefits of Credit Rating
For Investors & Banks

 An independent, unbiased and objective opinion on risk

 To assess the risk premium

 To effectively monitor and manage investments

For Regulators…

 To monitor financial soundness of organisations

 Promote transparency in the debt market

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Benefits of Credit Rating
For Enterprises

 An independent third-party evaluation

 Wide access to funds

 For pricing and timing of issues correctly

 Scope of self correction & self improvement


For Business counterparties

 For establishing business relationships

 For opening letters of credit, awarding contracts

 For entering into collaboration agreements

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


What is IPO Grading

• An independent and professional assessment of


equity issues offered to public

• An opinion on the “fundamentals” of the issuer

• Relative assessment of the issue in relation to the


universe of other listed peers

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Grading Methodology
•Industry dynamics, growth prospects, environment
Business fundamentals •Market position; competitive advantages; product mix
•Technology; operating efficiencies; cost structure

Promoter/management •Experience/background of promoters


•Management competence; functional allocation
evaluation
•Clarity of business strategy

•Trends in margins and profitability


Financial analysis •Financial flexibility and liquidity
•Financial projections

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


Grading Methodology

•Transparency; adequacy of disclosures


Accounting policies •Changes in accounting policy
•Auditors’ comments in annual reports

•Project completion risk – time and cost overruns


Project risk •Status of financial closure
•Required approvals for project

Corporate governance •Separation of ownership and management


•Size, composition and independence of board
practices
•Regulatory compliance

CARE Ratings – JOURNEY TOWARDS EXCELLENCE 30


IPO Grading Scale

Grading Definition
IPO Grade 5 Strong fundamentals.
IPO Grade 4 Good fundamentals.

IPO Grade 3 Average fundamentals.

IPO Grade 2 Below Average fundamentals.

IPO Grade 1 Poor fundamentals.

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


CARE EQUI-GRADE
• The critical factors considered by an investor while investing in a particular company’s
equity share are:

Whether the company is fundamentally sound with respect to its business, its
FUNDAMENTALS
financial position, its management and its prospects

What return can the investment potentially offer, which in turn is based on the
RETURN
LIQUIDITY Current Intrinsic Value (CIV) of the stock vis-a-vis its Current Market Price (CMP)

• CARE Independent Equity Research Product to be christened as ‘CARE Equi-Grade’


• CARE Equi-Grade shall touch upon all the three key parameters considered by the
investor before making any investment decision

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


PARAMETERS CONSIDERED

FUNDAMENTALS STOCK LIQUIDITY

Business Fundamentals CARE to choose apt


and Prospects valuation methodology

DCF, P/E, P/BV,


Financial Soundness EV/EBITDA, NAV,
Replacement Cost, etc.

Independent Financial
Management Quality
Projections

Current Intrinsic Value v/s


Corporate Governance Current Market Price
(Return Potential)

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


BENEFITS TO THE COMPANY
• With unbiased opinion available, the investor confidence in the company
increases.

• This leads to increase in trading volumes on the stock exchange

• Companies can easily raise funds from the market, both equity as well as
debt, as CARE IER provides grading on both fundamentals of the company
and valuation of its equity.

• Ease in raising long term debt based on Fundamental Grade


• Ease in private placement of company’s equity based on Valuation
Grade
• Ease in raising equity through follow-on public offers, right issues, etc.

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


About CARE Ratings

CARE Ratings – JOURNEY TOWARDS EXCELLENCE 35


Second Largest Rating Agency in India

CARE Ratings – JOURNEY TOWARDS EXCELLENCE 36


Major Shareholders

IDBI Bank
Canara First
Bank Leasing

State
Tata
Bank of
Group
India
CARE
IL&FS Sundaram
Group Finance

ING Vysya Federal


Bank Bank

CARE Ratings – JOURNEY TOWARDS EXCELLENCE 37


An Independent External Rating Committee
Mr. Y. H. Malegam Chairman
Former Managing Partner, S.B. Billimoria & Co.; Member of Board of
Directors of a number of companies and organizations including Reserve
Bank of India
Mr. S. Doreswamy Former CMD, Central Bank of India and Dena Bank

Mr. V. Leeladhar Former Dy. Governor, Reserve Bank of India.

Mr. V.K. Chopra Former Wholetime Member of Securities & Exchange Board of India and
Chairman and Managing Director of Corporation Bank.

Mr.P.P.Pattanayak Former Managing Director of State Bank of Mysore.


Former Dy. Managing Director & Chief Credit Officer of State Bank of
India

Mr. D. R. Dogra MD & CEO

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


38
Leadership Position in
Indian Banks / FIs Ratings

Rating of 51 Indian Banks & FIs


Substantial rating coverage of NBFCs &
HFCs
Rating diverse financial entities

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


39
Leadership in Various Sectors

 Construction & Real Estate


 Power Transmission
 Shipping & Shipyards
 Hospitality Sector
 Steel & Steel Products
 Telecom
 Textiles
 Cement

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


40
Leadership Position in
Sub Sovereign Ratings

All rated Indian


states have a
CARE rating

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


41
Leadership Position in
IPO Grading

Achieved Market Leadership in IPO grading

43% Market Share

82 IPOs Graded

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


42
Leadership Position in
Structured Finance
 Leadership in ABS & MBS rating
 More than 40% market share in current financial year
 More than ` 9,000 crore of pools rated in FY’10
 Highly stable ratings (no downgrades or defaults till
date)
 Largest securitization in Asia(Japan) and Largest
Single CLO rated

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


43
International Footprint

Technical assistance to Rating Agencies in


Mexico
Ecuador
Bangladesh
Nepal
Assignments for ADB

Founder member of Association of Credit Rating


Agencies in Asia (ACRAA)

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


44
Why CARE?

Impressive Track Record of more than 17 years


Approved by RBI/ SEBI / Other Regulators
Empanelment with NSIC for SSI Ratings
Best practices IOSCO Code of Conduct
Comparable Transition Matrix / CDR
Independent Rating Committee

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


45
Why CARE?

Ratings widely accepted by market participants

Capability

Highest number of ratings in shortest span of


time

Capable team of more than 200 analysts &


growing

CARE Ratings – JOURNEY TOWARDS EXCELLENCE


46
Marketing Associate

Incentive driven partnering options for CAs & CSs


for origination of rating business

CARE Ratings – JOURNEY TOWARDS EXCELLENCE 47


Thank You

CARE Ratings – JOURNEY TOWARDS EXCELLENCE 48

Vous aimerez peut-être aussi